Tu Z - Search Results

1

Synthesis and biological characterization of stable and radioiodinated (+/-)-trans-2-hydroxy-3-P[4-(3-iodophenyl)piperidyl]-1,2,3,4-tetrahydronaphthalene (3'-IBVM).

Efange SM, von Hohenberg K, Khare AB, Tu Z, Mach RH, Parsons SM. Efange SM, et al. Among authors: tu z. Nucl Med Biol. 2000 Nov;27(8):749-55. doi: 10.1016/s0969-8051(00)00157-8. Nucl Med Biol. 2000. PMID: 11150707

2

2-(2-Piperidyl)- and 2-(2-pyrrolidyl)chromans as nicotine agonists: synthesis and preliminary pharmacological characterization.

Efange SM, Tu Z, von Hohenberg K, Francesconi L, Howell RC, Rampersad MV, Todaro LJ, Papke RL, Kung MP. Efange SM, et al. Among authors: tu z. J Med Chem. 2001 Dec 20;44(26):4704-15. doi: 10.1021/jm010129z. J Med Chem. 2001. PMID: 11741488

3

Chromaproline and Chromaperidine, nicotine agonists, and Donepezil, cholinesterase inhibitor, enhance performance of memory tasks in ovariectomized rats.

Luine VN, Mohan G, Tu Z, Efange SM. Luine VN, et al. Among authors: tu z. Pharmacol Biochem Behav. 2002 Dec;74(1):213-20. doi: 10.1016/s0091-3057(02)00988-7. Pharmacol Biochem Behav. 2002. PMID: 12376170

4

Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands.

Chu W, Tu Z, McElveen E, Xu J, Taylor M, Luedtke RR, Mach RH. Chu W, et al. Among authors: tu z. Bioorg Med Chem. 2005 Jan 3;13(1):77-87. doi: 10.1016/j.bmc.2004.09.054. Bioorg Med Chem. 2005. PMID: 15582454

5

Carbon-11 labeled sigma2 receptor ligands for imaging breast cancer.

Tu Z, Dence CS, Ponde DE, Jones L, Wheeler KT, Welch MJ, Mach RH. Tu Z, et al. Nucl Med Biol. 2005 Jul;32(5):423-30. doi: 10.1016/j.nucmedbio.2005.03.008. Nucl Med Biol. 2005. PMID: 15982571

6

Synthesis and in vivo evaluation of [11C]PJ34, a potential radiotracer for imaging the role of PARP-1 in necrosis.

Tu Z, Chu W, Zhang J, Dence CS, Welch MJ, Mach RH. Tu Z, et al. Nucl Med Biol. 2005 Jul;32(5):437-43. doi: 10.1016/j.nucmedbio.2005.03.001. Nucl Med Biol. 2005. PMID: 15982573

7

Synthesis and characterization of selective dopamine D2 receptor antagonists.

Vangveravong S, McElveen E, Taylor M, Xu J, Tu Z, Luedtke RR, Mach RH. Vangveravong S, et al. Among authors: tu z. Bioorg Med Chem. 2006 Feb 1;14(3):815-25. doi: 10.1016/j.bmc.2005.09.008. Epub 2005 Nov 8. Bioorg Med Chem. 2006. PMID: 16288878

8

[3H]N-[4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl]-2-methoxy-5-methylbenzamide: a novel sigma-2 receptor probe.

Xu J, Tu Z, Jones LA, Vangveravong S, Wheeler KT, Mach RH. Xu J, et al. Among authors: tu z. Eur J Pharmacol. 2005 Nov 21;525(1-3):8-17. doi: 10.1016/j.ejphar.2005.09.063. Epub 2005 Nov 10. Eur J Pharmacol. 2005. PMID: 16289030

9

Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker.

Hou C, Tu Z, Mach R, Kung HF, Kung MP. Hou C, et al. Among authors: tu z. Nucl Med Biol. 2006 Feb;33(2):203-9. doi: 10.1016/j.nucmedbio.2005.10.001. Nucl Med Biol. 2006. PMID: 16546674

10

Synthesis and in vivo evaluation of 2 high-affinity 76Br-labeled sigma2-receptor ligands.

Rowland DJ, Tu Z, Xu J, Ponde D, Mach RH, Welch MJ. Rowland DJ, et al. Among authors: tu z. J Nucl Med. 2006 Jun;47(6):1041-8. J Nucl Med. 2006. PMID: 16741315 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,400 results

Search Page

Filters